David Soergel
Sr. VP, Clinical Development, Trevena Inc.
Companies
- MADRIGAL PHARMACEUTICALS, INC.Chief Medical Officer Apr 24, 2025 to now1
- Trevena IncSr. VP, Clinical Development Jan 30, 2014 to Mar 3, 20172
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- MADRIGAL PHARMACEUTICALS, INC. MDGL10,033 shares3$4.6M at $459.81Jun 1, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 1, 2026Sold 1,042 shares at $495.74 of MADRIGAL PHARMACEUTICALS, INC.3
- May 18, 2026Sold 844 shares at $515.90 of MADRIGAL PHARMACEUTICALS, INC.4
- Mar 4, 2026Granted 4,374 shares of MADRIGAL PHARMACEUTICALS, INC.5
- May 15, 2025Granted 7,545 shares of MADRIGAL PHARMACEUTICALS, INC.6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed May 18, 2026
- 5SEC EDGARForm 4 filed Mar 6, 2026
- 6SEC EDGARForm 4 filed May 16, 2025